By Dorothy Atkins ( October 19, 2017, 2:18 PM EDT) -- A Washington federal judge on Wednesday tossed a shareholder suit claiming a biotechnology company misled investors about the viability of its new leukemia treatment and concealed concerns the drug causes liver damage, finding the investors hadn't sufficiently alleged the company intended to mislead them, but left the door open for them to amend their complaint....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.